INtravenous Iron and eryThropoietin to treat Anaemia following CriTical care-2 (INTACT-2): A multi-centre, randomised, parallel group, double blind, placebo controlled clinical efficacy trial

Project Details

StatusActive
Effective start/end date1/08/2430/11/27

Funding

  • National Institute for Health Research: £1,591,450.15
  • National Institute for Health Research: £19,201.01